Virtual Medicinal Product (VMP) - Fluticasone 50micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free

Navigation

Name Details

Name Start Date End Date
Name Current Name Fluticasone 50micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free Start Date 16-08-2006 End Date
Previous Name Previous Name Fluticasone 50micrograms/actuation / Salmeterol 25micrograms/actuation inhaler CFC free Start Date 02-12-2002 End Date 15-08-2006
Abbreviated Name Abbreviated Name Fluticasone 50microg / Salmeterol 25microg/dose inh CFC free Start Date 16-08-2006
Previous Abbreviated Name Fluticasone 50microg / Salmeterol 25microg/act inh CFC free Previous Start Date 29-12-2002 Previous End Date 15-08-2006

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
dose
Unit Dose UOM
dose

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Pressurised inhalation
Ontology Form/Route
pressurizedinhalation.inhalation
Free From
CFC-free
Name Basis
Other

Codes

ATC Code
R03AK06
BNF Start Date End Date
Current BNF 03020000 Start Date 04-04-2022 End Date
Previous BNF 03020000 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39111011000001108 21-10-2020
320274007 02-12-2002 20-10-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Fluticasone propionate Based on Ingredient Substance 50 microgram 1 dose
Salmeterol xinafoate Based on Base Substance Salmeterol 25 microgram 1 dose

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
120 dose 1746 Part VIIIA Category C